Axol Bioscience acquires Phenocell to advance human disease models

Axol Bioscience Ltd. (Axol), a leading induced pluripotent stem cell (iPSC) technology provider for drug discovery, today announced it has fully acquired Phenocell SAS, a pioneer in iPSC-based products and bioassays for skin and retinal disorders.

Yes, Congress Finally Funded Health Spending for 2024

Something important for the world of healthcare happened very quietly a week and a half ago: President Biden signed the fiscal year (FY) 2024 appropriations

April 4, 2024

GH Research Reports Second Quarter 2023 Financial Results and Provides Business Updates – Psychedelic Alpha

DUBLIN, Ireland, Aug. 23, 2023 (GLOBE NEWSWIRE) — GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and

August 23, 2023

Study shows arterial stiffness as a novel cause of premature heart damage among adolescents

Arterial stiffness is a novel cause of premature heart damage among adolescents, according to a new follow-up study.

August 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.